Olmesartan dosage forms and strengths

Revision as of 20:27, 21 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Olmesartan}} {{CMG}}; {{AE}} {{SS}} ==Dosage Forms and Strengths== *5 mg yellow, round, film-coated, non-scored tablets debossed with Sankyo on one side and C12 ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Olmesartan
BENICAR® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Olmesartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Dosage Forms and Strengths

  • 5 mg yellow, round, film-coated, non-scored tablets debossed with Sankyo on one side and C12 on the other side
  • 20 mg white, round, film-coated, non-scored tablets debossed with Sankyo on one side and C14 on the other side
  • 40 mg white, oval-shaped, film-coated, non-scored tablets debossed with Sankyo on one side and C15 on the other side[1]

References

  1. ↑ "BENICAR (OLMESARTAN MEDOXOMIL) TABLET, FILM COATED [DAIICHI SANKYO, INC]". Retrieved 21 February 2014.

Template:Angiotensin II receptor antagonists

Retrieved from "https://www.wikidoc.org/index.php?title=Olmesartan_dosage_forms_and_strengths&oldid=946409"